KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infection

FEMS Microbiology Letters

Volumn 215, Issue 1, 2002, Pages 149-155

  Haralambieva, Iana ^a   Iankov, Ianko ^a   Mitev, Vanio ^a   Mitov, Ivan ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Chlamydia pneumoniae; Fibroblasts; Infectivity; KN 62; Mitogen activated protein kinase; Signal transduction

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN P42; PROTEIN P44; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPERIMENTAL INFECTION; FIBROBLAST; HOST PATHOGEN INTERACTION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ANTIGENS, BACTERIAL; BUTADIENES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL LINE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHORYLATION; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; MURINAE;

EID: 0037167476     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)00928-X     Document Type: Article

References (32)

1. Beaty C.D., Grayston J.T., Wang S.P., Kuo C.C., Reto C.S., Martin T.R. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 144:1991;1408-1410.
2. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA. 266:1991;225-230.
3. Black C.M., Bullard J.C., Staton G.W., Hutwagner L.C., Perez R.L. Seroprevalence of Chlamydia pneumoniae antibodies in patients with pulmonary sarcoidosis in north central Georgia. Proc. Eur. Soc. Chlamydia Res. 2:1992;175A.
4. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
5. Shor A., Kuo C.C., Patton D.L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82:1992;158-161.
6. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:1993;841-849.
7. Jackson L.A., Campbell L.A., Kuo C.C., Rodriguez D.I., Lee A., Grayston J.T. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176:1997;292-295.
8. Godzik K.L., O'Brien E.R., Wang S.K., Kuo C.C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33:1995;2411-2414.
9. Gaydos C.A., Summersgill J.T., Sahney N.N., Ramirez J.A., Quinn T.C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1996;1614-1620.
10. Krüll M., Klucken A.C., Wuppermann F.N., Fuhrmann O., Magerl C., Seybold J., Hippenstiel S., Hegemann J.H., Jantos C.A., Suttorp N. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol. 162:1999;4834-4841.
11. Kol A., Bourcier T., Lichtman A.H., Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103:1999;571-577.
12. Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S., Equils O., Morrison S.G., Morrison R.P., Arditi M. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168:2002;1435-1440.
13. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:2001;244-250.
14. Newhall W.J., Terho P., Wilde C.E., Batteiger B.E., Jones R.B. Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies. J. Clin. Microbiol. 23:1986;333-338.
15. Haralambieva I., Iankov I., Petrov D., Ivanova R., Kamarinchev B., Mitov I. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: Implications for diagnosis. Diagn. Microbiol. Infect. Dis. 41:2001;99-106.
16. Haralambieva I., Iankov I., Petrov D., Mladenov I., Mitov I. Monoclonal antibody of IgG isotype against a cross-reactive lipopolysaccharide epitope of Chlamydia and Salmonella Re chemotype enhances infectivity in L-929 fibroblast cells. FEMS Immunol. Med. Microbiol. 33:2002;71-76.
17. Kauppinen M., Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin. Infect. Dis. 21:1995;S244-S252.
18. Kalayoglu M.V., Indrawati, Morrison R.P., Morrison S.G., Yuan Y., Byrne G.I. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J. Infect. Dis. 181:2000;S483-S489.
19. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature. 410:2001;37-40.
20. Kol A., Lichtman A.H., Finberg R.W., Libby P., Kurt-Jones E.A. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164:2000;13-17.
21. Brade H., Brabetz W., Brade L., Holst O., Löbau S., Lucakova M., Mamat U., Rozalski A., Zych K., Kosma P. Chlamydial lipopolysaccharide. J. Endotoxin Res. 4:1997;67-84.
22. Mitev V., Le Panse R., Coulomb B., Miteva L., Houdebine L.M. Epidermal growth factor stimulates mitogen-activated protein kinase by a protein kinase C dependent pathway in human keratinocytes. Biochem. Biophys. Res. Commun. 208:1995;245-252.
23. Le Panse R., Mitev V., Houdebine L.M., Coulomb B. Protein kinase C independent activation of mitogen-activated protein kinase by epidermal growth factor in skin fibroblasts. Eur. J. Pharmacol. 307:1996;339-345.
24. Iankov I., Praskova M., Kalenderova S., Tencheva Z., Mitov I., Mitev V. The effect of chemical blockade of PKC with Gö6976 and Gö6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cells. Leuk. Res. 26:2002;363-368.
25. Schmitt J.M., Stork P.J. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol. Cell. 9:2002;85-94.
26. Clapman D. Calcium signaling. Cell. 80:1995;259-268.
27. 2+/calmodulin dependent protein kinase cascade. Trends Biochem. Sci. 24:1999;232-236.
28. Tokumitsu H., Chijiwa T., Hagiwara M., Mizutani A., Terasawa M., Hidaka H. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:1990;4315-4320.
29. 2+/calmodulin dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of culture rat aortic smooth muscle cells. Circ. Res. 81:1997;575-584.
30. Huang S., Maher V.M., McCormick J. Involvement of intermediary metabolites in the pathway of extracellular Ca2+-induced mitogen-activated protein kinase activation in human fibroblasts. Cell. Signal. 11:1999;263-274.
31. Lck and CaM-kunase. Mol. Immunol. 37:2000;675-683.
32. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases and apoptosis. Science. 270:1995;1326-1331.